Navigation Links
10th Functional Genomics: Chemical Biology 2009

A cure for cystic fibrosis, HIV-fighting 'Trojan horses', new pharmaceuticals from the ocean. Chemical biologists use new and innovative approaches to discover medications of the future. On 24 August, some of the field's most prominent researchers will attend an international conference in Gothenburg, Sweden.

In the field of chemical biology, chemists and biologists cooperate to investigate, and eventually control, the behavior of cells. The scientists use small molecules that activate certain proteins to study how cells communicate, and ultimately they want to be able to prevent disease-causing interactions and understand how medicines and environmental toxins work on a cellular level.

The potential applications of research in chemical biology are unlimited. A number of serious diseases that lack effective treatments are currently being studied. Many of them will be discussed on 24-25 August when the University of Gothenburg and Chalmers University of Technology host the Functional Genomics/Chemical Biology conference in Gothenburg, Sweden:

  • Professor Carsten Schultz from the European Molecular Biology Laboratory (EMBL) in Heidelberg is developing new tools that will help us better understand cystic fibrosis. By visualising how cell signaling goes awry, Schultz hopes to come closer to finding a treatment for the incurable disease.

  • Ronald Raines from the University of Wisconsin has designed a 'Trojan horse' - an enzyme that infiltrates and then attacks the viruses that cause HIV and the lung disease SARS.

  • Guri Giaever from the University of Toronto uses yeast to investigate the action mechanism of medicines. Giaver is working together with pharmaceutical companies to explore and eliminate side effects of medicines.

  • Henrik Pavia is a University of Gothenburg marine ecologist and an expert in how marine organisms produce and utilise chemical substances. At the conference, Pavia will share the latest knowledge on how these marine bioactive substances can be used to create medicines for humans.

The conference, held at the Chalmers Conference Centre, will also present new findings about environmental toxins and the research currently carried out to identify how molecules in the cell are affected by the toxins.


Contact: Per Sunnerhagen
University of Gothenburg

Related biology news :

1. Researchers expand efforts to explore functional landscape of the human genome
2. The endocannabinoids: Functional roles and therapeutic opportunities
3. RevGenUK, a single-stop shop for use in functional genomics
4. Junk DNA proves functional
5. Researchers generate functional neurons from somatic cells
6. ADA releases updated position statement on functional foods
7. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
8. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
9. Thermochemical process converts poultry litter into bio-oil
10. New chemically-sensitive MRI scan may bypass some invasive diagnostic tests in next decade
11. Natural chemical found in broccoli helps combat skin blistering disease
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015  BIOCLAIM announced ... finalist in this year,s Fierce Innovation Awards:  Healthcare Edition, ... FierceHealthIT , FierceHealthcare , ... as a finalist in the category of "Privacy ... --> --> ...
(Date:11/26/2015)... 2015 Research and Markets ( ) ... Sensors - Technology and Patent Infringement Risk Analysis" ... --> Fingerprint sensors using capacitive technology ... fingerprint sensor vendor Idex forecasts an increase of 360% ... devices and of the fingerprint sensor market between 2014 ...
(Date:11/20/2015)... Connecticut , November 20, 2015 ... authentication company focused on the growing mobile commerce market ... CEO, Gino Pereira , was recently interviewed on ... interview will air on this weekend on Bloomberg ... Latin America . --> NXTD ) ("NXT-ID" ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... Md. , Nov. 25, 2015  PharmAthene, Inc. ... Directors has adopted a stockholder rights plan (Rights Plan) ... net operating loss carryforwards (NOLs) under Section 382 of ... --> PharmAthene,s use of its NOLs ... "ownership change" as defined in Section 382 of the ...
(Date:11/25/2015)... Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and CEO of Neurocrine Biosciences, will be presenting ... New York . ... website approximately 5 minutes prior to the presentation to ... the presentation will be available on the website approximately ...
(Date:11/25/2015)... The Global Genomics Industry ... and in-depth study on the current state of ... ) , The report provides ... classifications, applications and industry chain structure. The Genomics ... including development trends, competitive landscape analysis, and key ...
(Date:11/24/2015)... Cepheid (NASDAQ: CPHD ) today announced ... conference, and invited investors to participate via webcast. ... December 1, 2015 at 11.00 a.m. Eastern Time ... December 1, 2015 at 11.00 a.m. Eastern Time ... York, NY      Tuesday, December 1, 2015 at ...
Breaking Biology Technology: